New hope for kids with Tough-to-Treat leukemia
NCT ID NCT07354074
Summary
This study is testing a drug called asciminib in children and teenagers (ages 1 to under 18) with a specific type of chronic blood cancer called Philadelphia-positive chronic myeloid leukemia (CML). The goal is to see if the drug is safe and effective for kids, including those newly diagnosed and those whose previous treatments have stopped working or caused severe side effects. The study will also monitor the children's growth and development over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOGENOUS LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.